<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04706455</url>
  </required_header>
  <id_info>
    <org_study_id>20210312</org_study_id>
    <nct_id>NCT04706455</nct_id>
  </id_info>
  <brief_title>Effect of Artificial Tears on the Parameters of the Eye and Its Impact on IOL Power Calculation for Cataract Surgery</brief_title>
  <acronym>IOL</acronym>
  <official_title>Effect of Artificial Tears on the Parameters of the Eye in Normal and Dry Eyes and Its Impact on IOL Power Calculation for Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital of Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital of Xi'an Jiaotong University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      First, preoperative biometry of the eye at the IOL Master® will be performed. Then, corneal&#xD;
      topography will be measured at the Oculus pentacam®. Afterwards, one of two eye drops are&#xD;
      instilled in the eye, and biometry and corneal topography will be repeated after 5 minutes.&#xD;
&#xD;
      For all patients, the Barrett Universal II formula will be used for calculation of IOL power.&#xD;
      Predicted refraction outcome will be referred to as SEQ. The chief surgeon will perform the&#xD;
      uneventful standard cataract operation with in-the-bag implantation of a HOYA IOL (Model 251)&#xD;
      through a 2.4-mm corneal incision.&#xD;
&#xD;
      A Subjective Refraction using plus principle will be performed one month after the operation,&#xD;
      and ETDRS visual acuity charts will be used to measure best-corrected visual acuity.&#xD;
      Refraction will be described as SR (postoperative SEQ) and will be calculated as:&#xD;
&#xD;
      SR = sphere + (0.5*cylinder)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      First, preoperative biometry of the eye at the IOL Master® will be performed. Then, corneal&#xD;
      topography will be measured at the Oculus pentacam®. Patients will be classified as dry eye&#xD;
      or normal eye based on BUT. The tear film breakup (BUT) time of less than 5 seconds will be&#xD;
      diagnosed as dry eyes.Afterwards, one of two eye drops are instilled in the eye, and biometry&#xD;
      and corneal topography will be repeated after 5 minutes.&#xD;
&#xD;
      For all patients, the Barrett Universal II formula will be used for calculation of IOL power.&#xD;
      Predicted refraction outcome will be referred to as SEQ. The chief surgeon will perform the&#xD;
      uneventful standard cataract operation with in-the-bag implantation of a HOYA IOL (Model 251)&#xD;
      through a 2.4-mm corneal incision.&#xD;
&#xD;
      A Subjective Refraction using plus principle will be performed one month after the operation,&#xD;
      and ETDRS visual acuity charts will be used to measure best-corrected visual acuity.&#xD;
      Refraction will be described as SR (postoperative SEQ) and will be calculated as:&#xD;
&#xD;
      SR = sphere + (0.5*cylinder)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Corneal topography and Biometry will be performed in individuals with age-relate cataract. Patients will be classified as dry eye or normal eye based on BUT. The tear film breakup (BUT) time of less than 5 seconds will be diagnosed as dry eyes. One of two artificial tear eye drops will be instilled in the eye, and corneal topography and biometry will be repeated after 5 minutes of application</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>keratometric value of the eye measured with Master 500 before and after 5 minutes of installation of artificial tears (sodium hyaluronate 0.1% or 0.3% eye drops).</measure>
    <time_frame>5 minutes</time_frame>
    <description>k-value (k, k1, k2 in Diopter)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Axial length of the eye measured with Master 500 before and after 5 minutes of installation of artificial tears (sodium hyaluronate 0.1% or 0.3% eye drops).</measure>
    <time_frame>5 minutes</time_frame>
    <description>Axial length (AL in mm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anterior chamber depth of the eye measured with Master 500 before and after 5 minutes of installation of artificial tears (sodium hyaluronate 0.1% or 0.3% eye drops).</measure>
    <time_frame>5 minutes</time_frame>
    <description>Anterior chamber depth (ACD in mm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sim K of the eye measured with Oculus Pentacam before and after 5 minutes of installation of artificial tears (sodium hyaluronate 0.1% or 0.3% eye drops).</measure>
    <time_frame>5 minutes</time_frame>
    <description>Sim K (k1, k2 in Diopter)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Corneal Refractive Power of the eye measured with Oculus Pentacam before and after 5 minutes of installation of artificial tears (sodium hyaluronate 0.1% or 0.3% eye drops).</measure>
    <time_frame>5 minutes</time_frame>
    <description>Total Corneal Refractive Power (TCRP in Diopter),</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Corneal Irregular Astigmatism of the eye measured with Oculus Pentacam before and after 5 minutes of installation of artificial tears (sodium hyaluronate 0.1% or 0.3% eye drops).</measure>
    <time_frame>5 minutes</time_frame>
    <description>Total Corneal Irregular Astigmatism (TCIA in Diopter)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Predicted spherical equivalent (SE) calculated with Barrett Universal II formula before and after 5 minutes of installation of artificial tears (sodium hyaluronate 0.1% or 0.3% eye drops).</measure>
    <time_frame>5 minutes</time_frame>
    <description>Predicted spherical equivalent (SEQ in Diopter)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative spherical equivalent (SE) measured one month after surgery.</measure>
    <time_frame>one month after surgery</time_frame>
    <description>Postoperative spherical equivalent (SE in Diopters)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cataract Senile</condition>
  <condition>Dry Eye</condition>
  <arm_group>
    <arm_group_label>sodium hyaluronate 0.1%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>First preoperative Biometry of the eye at the IOL Master® will be measured. Then, corneal topography will be measure at the Oculus pentacam®. Afterwards, sodium hyaluronate 0.1% will be installed and biometry and corneal topography will be repeated after 5 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sodium hyaluronate 0.3%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>First preoperative Biometry of the eye at the IOL Master® will be measured. Then,corneal topography will be measure at the Oculus pentacam®. Afterwards, sodium hyaluronate 0.3% will be installed and biometry and corneal topography will be repeated after 5 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sodium hyaluronate 0.1%</intervention_name>
    <description>Instillation of one drop sodium hyaluronate 0.1%</description>
    <arm_group_label>sodium hyaluronate 0.1%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sodium hyaluronate 0.3%</intervention_name>
    <description>Instillation of one drop sodium hyaluronate 0.3%</description>
    <arm_group_label>sodium hyaluronate 0.3%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A patient diagnosed with age related cataract&#xD;
&#xD;
          -  30 to 95 years old&#xD;
&#xD;
          -  Medical history and physical examination should be normal.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Abnormality of the cornea (scaring of the cornea)&#xD;
&#xD;
               -  If any topical therapy (i.e. glaucoma) of the eye is needed&#xD;
&#xD;
               -  Active allergy of eye or nose&#xD;
&#xD;
               -  Any conjunctivitis or keratitis&#xD;
&#xD;
               -  If nasolacrimal drainage apparatus is abnormal&#xD;
&#xD;
               -  severity level 4 of dry eye (constant discomfort in the eye accompanied with&#xD;
                  visual symptoms, filamentary keratitis, , keratinization, severe conjunctival&#xD;
                  injection, ulceration clumping of mucus glands, tear debris, , trichiasis,&#xD;
                  symblepharon)&#xD;
&#xD;
               -  deformities of lid&#xD;
&#xD;
               -  Preceding eye trauma or surgery&#xD;
&#xD;
               -  Any Uncontrolled ocular disease or systemic disease&#xD;
&#xD;
               -  Lactation&#xD;
&#xD;
               -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ling Bai, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Affiliated Hospital of Xi'an Jiaotong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ling Bai, MD,PhD</last_name>
    <phone>13571495415</phone>
    <email>larkling@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Ophthalmology, Second affiliated hospital of Xian Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ling Bai, MD,PhD</last_name>
      <phone>13571495415</phone>
      <email>larkling@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 20, 2020</study_first_submitted>
  <study_first_submitted_qc>January 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2021</study_first_posted>
  <last_update_submitted>January 10, 2021</last_update_submitted>
  <last_update_submitted_qc>January 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

